What Should a Fractional CMO Deliver in the First 90 Days?
A fractional CMO should leave the business with a clearer growth diagnosis, explicit choices, trusted measurement and real work running. Here is how to judge progress by days 30, 60 and 90.
A fractional CMO should not spend the first 90 days producing a strategy deck and a campaign calendar.
By day 90, the business should have a shared diagnosis of the growth constraint, a small number of explicit commercial choices, a measurement baseline the leadership team trusts, clear ownership, and real work running against those choices.
The campaigns depend on what the diagnosis finds. If the problem is weak product-market fit, launching demand faster is waste. If measurement is broken, adding channels creates more noise. If the team is capable but fragmented, restructuring it before understanding why the current system exists can destroy useful context.
That is the difference between a 90-day plan and a 90-day checklist.
If you are still deciding which leadership model fits the business, start with fractional CMO vs full-time CMO vs agency.
What should be different by day 90?
The useful test is not how many campaigns launched. It is whether the company is making better growth decisions and can explain why.
By the end of the first 90 days, I would expect five things to be materially clearer:
The constraint. Is growth being limited by product-market fit, ICP, positioning, demand, conversion, sales capacity, measurement or team capability?
The choices. What are we deliberately doing, not doing and stopping?
The numbers. Which commercial metrics are trusted enough to make budget and prioritisation decisions?
The ownership. Who owns each part of the growth system, including hand-offs between marketing, sales, product and external specialists?
The next evidence. What will prove that the current direction is working, and what would cause us to change it?
The first 90 days can create meaningful commercial movement, but it cannot compress every sales cycle into a quarter. In B2B SaaS and fintech, early evidence may be better conversion, higher-quality pipeline, stronger intent, lower acquisition waste, cleaner attribution or faster decisions rather than closed revenue.
The important thing is to separate findings, decisions, shipped work and observed impact. Blurring those together makes marketing look more certain than it is.
Days 1 to 30: diagnose before you prescribe
The first month is about getting to a commercial diagnosis quickly enough to act, without pretending you already know the answer.
I want to understand the market and ICP, proposition, acquisition mix and economics, funnel conversion, CRM and tracking, sales hand-offs, team and agency capacity, and the financial or operational constraint that should govern the first decisions.
That does not require a 100-page audit. The output should be short enough to use.
A simple stop, start, continue view often works better than a large strategy deck. It forces the conversation onto decisions. What are we paying for that no longer makes sense? What is missing? What is already working and should be protected?
There is still room for fast action in month one. Fix obvious tracking gaps. Stop clearly wasteful spend. Repair a broken landing page or hand-off. But treat any campaign launched before the diagnosis as a hypothesis, not proof that the strategy is settled.
If somebody can tell you exactly which campaign to run before they have seen the CRM, funnel and customer evidence, they are guessing with confidence.
What I would expect by day 30
You should have a commercial baseline, a clear diagnosis of the main constraint, an explicit list of assumptions and risks, a prioritised 90-day plan, and named owners.
You should also know what you do not know. Uncertainty that is visible can be tested. Uncertainty hidden inside a confident strategy becomes expensive.
Days 31 to 60: make the expensive choices
Month two is where the work becomes less about analysis and more about choosing.
Depending on the diagnosis, those choices might cover ICP and segment priority, positioning and offer, the primary acquisition motion, budget allocation, team and agency roles, CRM stages and metric definitions, the nurture and conversion journey, and which work stops so the team can focus.
I use two-week sprints because they force strategy into an operating rhythm. The live plan should show what is planned, in progress, shipped and what happened as a result. It is much harder for an engagement to drift when the work and decisions are visible.
This is also where it helps to distinguish reversible decisions from expensive, hard-to-reverse ones. Testing a landing-page proposition is cheap to undo. Hiring a team around an unproven channel is not. The level of evidence required should reflect the cost of being wrong.
Measurement should become useful at this point, not theoretically perfect. If your current reporting cannot reconcile spend, lead source, pipeline and revenue well enough to support a decision, fix that before layering on a more sophisticated attribution model.
What I would expect by day 60
The leadership team should be able to explain the growth strategy in a few sentences. The team should know the current priorities and who owns them. The main metrics should have definitions people agree on. The first priority work should be live or close to live.
If the business is still discussing every possible channel and customer segment at day 60, the fractional CMO has not narrowed the problem enough.
Days 61 to 90: prove, transfer and decide what happens next
The third month is where the work should become easier to inspect.
Priority work is now live. The team has enough evidence to compare assumptions with what actually happened. The question changes from “what should we do?” to “what did we learn, what should we double down on, and what should we stop?”
This is also the point where a fractional CMO should reduce dependency on themselves. I want the team to understand why the priorities changed, how the key metrics are defined, what decisions they can make without me, and what evidence should trigger a rethink.
A useful principle is to make strategic disagreement reversible where possible. Test the cheaper, reversible decision first. Put explicit success gates around it. Keep the progress visible. Save the higher-evidence threshold for decisions that are expensive to undo, such as senior hires, major budget shifts or a full repositioning.
The handover matters as much as the launch. A good engagement should leave behind a stronger operating system, not a collection of campaigns that only the fractional CMO understands.
What I would expect by day 90
By day 90, I would expect:
the main growth constraint to be explicit and supported by evidence;
the commercial choices and trade-offs to be understood by the leadership team;
priority work to be live, with early evidence against a baseline where the sales cycle allows it;
metric definitions, reporting and decision rules to be usable by the people who need them;
ownership and hand-offs to be clear;
a short backlog for the next phase, including what is being stopped;
a clear decision on whether the fractional engagement should continue, reduce, expand or hand over.
Closed revenue is not the universal test. What can reasonably be proved in 90 days depends on the sales cycle and the starting condition. The test is whether the business has better evidence, better decisions and enough execution underway to judge the next investment.
How the plan changes by bottleneck
A fixed 30/60/90 template is useful for cadence, but not for deciding the work. The bottleneck should change the plan.
Product-market fit or ICP: start with customer evidence, segment choice, proposition and retention or conversion signals. Do not scale acquisition into an unresolved market problem. By day 90, the useful evidence is a clearer target segment, stronger proposition and evidence that the chosen audience responds differently.
Demand: start with channel economics, offer, creative, landing journey and sales capacity. Do not add channels before understanding why the current ones fail. By day 90, priority acquisition work should be live with a baseline and an early quality or efficiency signal.
Measurement: start with metric definitions, CRM stages, source capture, pipeline and revenue reconciliation. Do not build a sophisticated attribution model on unreliable inputs. By day 90, leadership should be able to make a budget decision from reporting it understands and trusts.
Team and operating model: start with roles, decision rights, hand-offs, priorities and capability gaps. Do not restructure before learning why the current system exists. By day 90, the team should know what it owns, how work is prioritised and where outside help is genuinely needed.
This is why the first month matters. The same fractional CMO can enter four companies with similar revenue and produce four different 90-day plans.
How should a founder evaluate progress?
At the 90-day review, I would ask five questions.
Can we explain the growth constraint more precisely than we could three months ago? If not, the diagnosis has not done enough work.
Have we made choices? A strategy that leaves every segment, channel and initiative open is still a backlog.
Is the evidence getting better? Reporting does not have to be perfect, but it should be more trustworthy and more useful for decisions.
Is meaningful work shipping? Analysis without execution is consulting theatre. Execution without diagnosis is expensive guesswork.
Can the team make more of the right decisions without me? The engagement should be building clarity, capability and decision confidence.
I also look at the relationship with the existing team. Entering a business with a mandate to fix marketing is not a licence to redraw the organisation in week one. Learn why current practices exist, make the agenda explicit, provide useful support early and earn enough trust to change the parts that genuinely need changing.
What should remain after the engagement?
The most valuable outputs are often the things the business keeps using: a commercial diagnosis, agreed metric definitions, a prioritised backlog, decision rules, a working reporting view, clearer roles, and a cadence for reviewing evidence and changing course.
Campaigns matter, but they are temporary. A better way of making growth decisions is the asset.
That is also the standard I would use to judge a fractional CMO. The engagement should make itself less necessary over time.
Bottom line
The first 90 days should not be a race to prove how much activity a fractional CMO can create.
They should move the company from ambiguity to a shared diagnosis, from options to choices, from disputed numbers to usable evidence, and from plans to work that is actually running.
If you are evaluating a fractional CMO, use those outcomes as the brief. If we work together, they are also a fair standard to hold me to.